Celltrion’s Remsima SC Dominates the German Market with Impressive Growth
Remsima SC increases prescriptions by 10% every year in Germany… Remsima prescriptions also increased, achieving a combined market share of 67%. Begzelma signs exclusive contract with distributor holding 15% share of German bevacizumab market Herzuma surpasses original with 38% market share to become Germany’s No.1 trastuzumab prescription product ‘Remsima SC’, the world’s only infliximab subcutaneous […]
Groundbreaking Study on Predictors of Response to Biologic Agents for Ulcerative Colitis Presented at European Society of Inflammatory Bowel Diseases
Professor Kim So-un from the Department of Pathology gave an oral presentation to the European Society of Inflammatory Bowel Diseases. Professor Kim So-un from the Department of Pathology at Kyung Hee University Hospital presented the results of a study identifying predictors of response to treatment with biologic agents for ulcerative colitis at the European Society […]
Understanding Inflammatory Bowel Disease in Pets: Causes, Symptoms, and Treatment
Jang Bong-hwan, CEO of Good Morning Pet Animal Hospital Just like humans, pets also vomit and have diarrhea when they are sick. Temporary vomiting and diarrhea will improve without special treatment, but if they appear chronically more than once a week, you should suspect “inflammatory bowel disease.” Inflammatory bowel disease is a chronic disease that […]
Celltrion to Launch Zymfentra in US Market, First Shipment Announced
Picture = Celltrion Celltrion (Chairman Seo Jeong-jin) announced on the 28th that it would launch ‘Zymfentra (Remsima SC, US product name), a subcutaneous (SC) injection formulation containing infliximab.picture)’ its first shipment to the United States and announced that its launch in the US market will begin in earnest. The company plans to ship the initial […]
The Importance of Gut Health in Digestion, Immunity, and Mental Well-Being
It affects gut health, digestion and absorption, as well as immunity and mental health.Creating a healthy intestinal environment is important to improve “gut health” There is a saying: “Only when you lose your health do you understand its value.” It means there is nothing more precious than living a happy and healthy life. We present […]
Inflammatory Bowel Disease Linked to Higher Risk of Spinal Fractures: Study
Professor Seong-Hoon Jeong of Eunpyeong St. Mary’s Hospital and Professor Jun-Seok Lee’s team conducted a large-scale comparative study targeting around 130,000 people. Patients with inflammatory bowel disease have a higher risk of fractures than the general public, and patients with Crohn’s disease are more vulnerable. Research has shown that inflammatory bowel disease, which causes inflammation […]
The Impact of Fecal Transplantation: Menopausal Symptoms After Direct Transplant of Maternal Faeces
Fecal Transplant from Mother Leads Canadian Man to Develop Menopausal Symptoms Recently, a peculiar case of a man experiencing menopausal symptoms after receiving a fecal transplant from his mother has garnered attention. Charlie Curtis, a resident of Toronto, Canada, had undergone the transplant at home to alleviate symptoms of Crohn’s disease, but instead found himself […]
Detecting Subtle Physical Changes Before Inflammatory Bowel Disease Develops: A Breakthrough Study from the Francis Crick Institute
Breakthrough Research Revealed by Francis Crick Institute Early Detection of Inflammatory Bowel Disease A recent study conducted by the Francis Crick Institute, in collaboration with Aalborg University in Denmark, has unveiled groundbreaking findings regarding the early detection of inflammatory bowel disease (IBD). The research, published in Cell Reports Medicine, suggests that subtle physical changes indicative […]
Understanding the Impact of Systemic Diseases on Dental Treatment: A Comprehensive Guide
Systemic diseases to consider during dental treatment – A~Z 34 (PARAGRAPH) (A) Inflammatory Bowel Disease (IBD) According to Truelove and Witts, ulcerative colitis (UC) and Crohn’s disease (CD) are the most common forms of inflammatory bowel disease. The severity of ulcerative colitis (UC) is measured based on clinical and endoscopic severity. The clinical severity is […]
AbbVie’s Skyrizi Emerges as Strong Competitor in the IBD Market, Threatening Existing Treatments
AbbVie’s Skyrizi (risankizumab) has demonstrated superiority over Stelara (ustekinumab) in a direct comparison study among patients with Crohn’s disease, raising hopes that Skyrizi will establish itself as a dominant force in the field of inflammatory bowel disease (IBD). The phase 3 clinical trial results of Skyrizi were announced by AbbVie, revealing a head-to-head comparison of […]
